Literature DB >> 8780535

Clinicopathologic features of small pancreatic adenocarcinoma. A collective study.

H Furukawa1, S Okada, H Saisho, J Ariyama, E Karasawa, A Nakaizumi, S Nakazawa, K Murakami, T Kakizoe.   

Abstract

BACKGROUND: Early diagnosis and complete removal of pancreatic adenocarcinoma (PC) is essential to improve its poor prognosis. It is necessary to find PC when it is small and at an early stage if surgical treatment is to be successful. This is an investigation of the clinicopathologic features of small PC.
METHODS: Thirty-one resected and histopathologically examined cases of small PC, 2 cm or less in greatest dimension, were collected from 7 institutions between 1989 and 1994, and their clinicopathologic features were analyzed in detail.
RESULTS: Eighteen patients (58.1%) had some symptoms or signs at the time of diagnosis, however, the other 13 (41.9%) had no symptoms. There was no sensitive blood test for the detection of small PC. The detection rates of the pancreatic tumor mass on ultrasonography, endoscopic ultrasonography, and computed tomography were 64.5% (20/31), 73.7% (14/19), and 64.5% (20/31), respectively. Only 13 patients (41.9%) were in International Union Against Cancer (UICC) Stage I, and the other 18 were in Stage III or IV due to lymph node metastasis or peritoneal dissemination. The overall 4-year postoperative survival rate was 54.5% and that of patients in Stage I was 77.9%.
CONCLUSIONS: To detect a small PC, a thorough examination may be required in patients with slightly abnormal findings on laboratory tests or imaging modalities, even if the patient is asymptomatic. PC 2 cm or less and belonging to Stage I may be regarded as an early carcinoma, because of its good prognosis.

Entities:  

Mesh:

Year:  1996        PMID: 8780535     DOI: 10.1002/(SICI)1097-0142(19960901)78:5<986::AID-CNCR7>3.0.CO;2-A

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  33 in total

1.  Pathomorphological and histological prognostic factors in curatively resected ductal adenocarcinoma of the pancreas.

Authors:  W Meyer; C Jurowich; M Reichel; B Steinhäuser; P H Wünsch; C Gebhardt
Journal:  Surg Today       Date:  2000       Impact factor: 2.549

Review 2.  Endoscopic ultrasonography: imaging and beyond.

Authors:  T Rösch
Journal:  Gut       Date:  2003-08       Impact factor: 23.059

Review 3.  Hereditary pancreatic cancer.

Authors:  Shilpa Grover; Sapna Syngal
Journal:  Gastroenterology       Date:  2010-08-19       Impact factor: 22.682

Review 4.  Detecting early pancreatic cancer: problems and prospects.

Authors:  Suresh T Chari
Journal:  Semin Oncol       Date:  2007-08       Impact factor: 4.929

5.  Plectin-1 as a novel biomarker for pancreatic cancer.

Authors:  Dirk Bausch; Stephanie Thomas; Mari Mino-Kenudson; Castillo Carlos Fernández-del; Todd W Bauer; Mark Williams; Andrew L Warshaw; Sarah P Thayer; Kimberly A Kelly
Journal:  Clin Cancer Res       Date:  2010-11-23       Impact factor: 12.531

6.  Pancreatic ductal adenocarcinoma concomitant with intraductal papillary mucinous neoplasm: a report of 8 cases.

Authors:  Koichiro Mandai; Koji Uno; Kenjiro Yasuda
Journal:  Clin J Gastroenterol       Date:  2013-05-12

7.  Small multicentric pancreatic carcinoma usefully diagnosed by positron emission tomography.

Authors:  Chiaki Kamikado; Kouji Takumi; Tomomi Wakiyama; Akira Nakamura; Osamu Sawatani; Kazunari Kitazono; Takahisa Yoshida; Shuuhei Taguchi
Journal:  Clin J Gastroenterol       Date:  2009-11-26

8.  Intraductal tubular carcinoma in an adenoma of the main pancreatic duct of the pancreas head.

Authors:  Keita Itatsu; Tsuyoshi Sano; Nobuyoshi Hiraoka; Hidenori Ojima; Yu Takahashi; Yoshihiro Sakamoto; Kazuaki Shimada; Tomoo Kosuge
Journal:  J Gastroenterol       Date:  2006-07       Impact factor: 7.527

9.  Plasma protein profiling in a stage defined pancreatic cancer cohort - Implications for early diagnosis.

Authors:  Anna Sandström Gerdtsson; Christer Wingren; Helena Persson; Payam Delfani; Malin Nordström; He Ren; Xin Wen; Ulrika Ringdahl; Carl A K Borrebaeck; Jihui Hao
Journal:  Mol Oncol       Date:  2016-07-12       Impact factor: 6.603

10.  DNA methylation alterations in endoscopic retrograde cholangiopancreatography brush samples of patients with suspected pancreaticobiliary disease.

Authors:  Mansour A Parsi; Ang Li; Chung-Pin Li; Michael Goggins
Journal:  Clin Gastroenterol Hepatol       Date:  2008-09-05       Impact factor: 11.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.